title: Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
authors.affiliation: University and Regional Laboratories Region Scania, Clinical Chemistry, Malmö, Sweden. andreas.hillarp@med.lu.se
authors.forename: A
authors.initials: A
authors.lastname: Hillarp
authors.forename: F
authors.initials: F
authors.lastname: Baghaei
authors.forename: I
authors.initials: I
authors.lastname: Fagerberg Blixter
authors.forename: K M
authors.initials: KM
authors.lastname: Gustafsson
authors.forename: L
authors.initials: L
authors.lastname: Stigendal
authors.forename: M
authors.initials: M
authors.lastname: Sten-Linder
authors.forename: K
authors.initials: K
authors.lastname: Strandberg
authors.forename: T L
authors.initials: TL
authors.lastname: Lindahl